论文部分内容阅读
目的探讨莫西沙星经验性治疗青年社区获得性肺炎(CAP)的疗效,方法选择青年CAP患者76例,随机分为莫西沙星组(治疗组)和头孢噻肟组(对照组)各38例。其中莫西沙星注射液400mg,每天一次,静脉滴注。头孢噻肟注射液,每天6.0,分2次静脉滴注,总疗程7—14天。结果治疗组有效率94.7%,明显高于对照组68.0%(P<0.05),治疗组细菌清除率89.0%,也明显高于对照组64.0%(P<0.05)。结论莫西沙星是治疗青年CAP的优选方案。
Objective To investigate the curative effect of moxifloxacin on empiric treatment of community-acquired pneumonia (CAP) in young people.Methods 76 young patients with CAP were randomly divided into three groups: moxifloxacin group (treatment group) and cefotaxime group (control group), 38 cases . One moxifloxacin injection 400mg, once daily, intravenous infusion. Cefotaxime injection, 6.0 per day, divided by 2 intravenous infusion, the total course of 7-14 days. Results The effective rate of the treatment group was 94.7%, significantly higher than that of the control group (68.0%, P <0.05). The bacterial clearance rate of the treatment group was 89.0%, which was also significantly higher than that of the control group (64.0%, P <0.05). Conclusion Moxifloxacin is the optimal treatment for young patients with CAP.